Prospective quality of life impact of actinic keratoses: Observations from the veterans affairs topical tretinoin chemoprevention trial

Acta Dermato-Venereologica

Volumn 91, Issue 1, 2011, Pages 101-102

  Lee, Kachiu C ^a,b   Weinstock, Martin A ^a,c  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ACTINIC KERATOSIS; AGED; CHEMOPROPHYLAXIS; CROSS-SECTIONAL STUDY; DRUG EFFICACY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK FACTOR; TREATMENT OUTCOME; VETERAN;

ADMINISTRATION, TOPICAL; AGED; CHEMOPREVENTION; FEMALE; HUMANS; KERATOLYTIC AGENTS; KERATOSIS, ACTINIC; MALE; QUALITY OF LIFE; SKIN NEOPLASMS; TRETINOIN;

EID: 78751539179     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0972     Document Type: Letter

References (6)

1. Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF. Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 2009; 115: 2523-2530.
2. Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006; 55: 490-500.
3. Weinstock M.A, Lee K.C, Chren M.M, Marcolivio K; VATTC Trial Group. Quality of life in the actinic neoplasia syndrome: the VA Topical Tretinoin Chemoprevention (VATTC) Trial. J Am Acad Dermatol 2009; 61: 207-215.
4. Weinstock MA, Bingham SF, Lew RA, Hall R, Eilers D, Kirsner R, et al. Topical tretinoin therapy and all-cause mortality. Arch Dermatol 2009; 145: 18-24.
5. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-1440.
6. Weinstock MA, Bingham SF, Cole GW, Eilers D, Naylor MF, Kalivas J, et al. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial. Arch Dermatol 2001; 137: 1055-1058.